Archive: December 2025
Highlights in Multiple Myeloma
From the 2025 American Society of Hematology Annual Meeting December 6-9, 2025 • Orlando, Florida Teclistamab/Daratumumab Combination Improves Survival in Relapsed/Refractory Myeloma Progression-free survival (PFS) and […]
Ravulizumab–Danicopan Combination Therapy in PNH Management
In the Clinic AB presented to our clinic in 2017, at the age of 70, for a second opinion regarding management of paroxysmal nocturnal hemoglobinuria (PNH) […]